Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort

February 25, 2026 | John Murphy | Leave a Comment

Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort

Nature Communications volume 16, Article number: 9557 (2025) Abstract Longitudinal trajectories of Long COVID remain ill-defined, yet are critically needed to advance clinical trials, patient care, and public health initiatives for millions of individuals with…[...]

January 25, 2026 | John Murphy | Leave a Comment

The Problem Of Fake Science

Authored by Jeffrey Tucker via The Epoch Times, Last week, I was able to generate from artificial intelligence a fake study that proved that eating waffles increases baldness. It was…[...]

January 9, 2026 | John Murphy | Leave a Comment

Data-driven RECOVER research produces new discoveries about Long COVID.

This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]

November 22, 2025 | John Murphy | Leave a Comment

Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options…[...]

November 19, 2025 | John Murphy | Leave a Comment

COVID Research Gaps and Future Directions: Standardization, Longitudinal Recovery, AI-Driven Biomarkers, and Policy Reform

Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), remains a poorly defined and under-researched condition affecting millions globally. Despite its prevalence,…[...]

November 12, 2025 | John Murphy | Leave a Comment

Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment

Abstract Despite the global burden of Long COVID, the medical profession has demonstrated a striking reluctance to engage in consistent diagnosis, treatment, and research. This article explores the multifactorial roots…[...]

August 13, 2025 | John Murphy | Leave a Comment

Data-driven RECOVER research produces new discoveries about Long COVID.

This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]

August 6, 2025 | John Murphy | Leave a Comment

Data-driven RECOVER research produces new discoveries about Long COVID.

This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]

July 23, 2025 | John Murphy | Leave a Comment

🧪 What Long-Term Safety Studies Are Still Needed for COVID Vaccines?

Despite billions of doses administered, some areas remain under-researched: 🔹 Obstetric and Reproductive Health Pregnancy outcomes: While short-term studies show no increase in miscarriage or birth defects, long-term effects on…[...]

July 15, 2025 | John Murphy | Leave a Comment

Pfizer COVID Vaccine Suggests Some People Got Highly Dangerous Shots, Others Got a Placebo

Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches…[...]